Associated Papers
Clinical implications of experimental analyses of AID function on predictive computational tools: Challenge of missense variants.
Abolhassani H et al.
Clinical Genetics, 2020
Activation-induced cytidine deaminase targets SUV4-20-mediated histone H4K20 trimethylation to class-switch recombination sites.
Rodríguez-Cortez VC et al.
Scientific Reports, 2017
AID and Apobec3G haphazard deamination and mutational diversity.
Jaszczur M et al.
Cellular and Molecular Life Sciences : Cmls, 2013
A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
Caratão N et al.
Clinical Immunology (orlando, Fla.), 2013
A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants.
Mu Y et al.
The Journal of Biological Chemistry, 2012
Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome.
Mahdaviani SA et al.
Expert Review of Clinical Immunology, 2012
Inherited defects of immunoglobulin class switch recombination.
Kracker S et al.
Advances in Experimental Medicine and Biology, 2010
Molecular genetic analysis of Hungarian patients with the hyper-immunoglobulin M syndrome.
Erdos M et al.
Molecular Immunology, 2008
Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.
Lee WI et al.
Blood, 2005
AID mutant analyses indicate requirement for class-switch-specific cofactors.
Ta VT et al.
Nature Immunology, 2003
Select a paper to view details